Kymab
Latest round
- Series C
Last raised
- Nov 2016
Total raised
- $101M
Investors
- 6
About Kymab
Kymab Ltd.Founded in 2010 in Cambridge, UK, Kymab Ltd. specializes in the discovery and development of monoclonal antibodies.A.1 bn and potential milestone payments of up to USD 350 mn.Kymab specializes in the development and commercialization of innovative therapeutic antibodies aimed at addressing significant unmet medical needs. The company’s core product offerings include monoclonal antibodies that leverage its proprietary technologies to enhance drug efficacy and safety. These therapeutics are particularly focused on treating autoimmune diseases and cancer, with the goal of improving patient outcomes through targeted action. Kymab has built a diverse client base that includes pharmaceutical companies and research institutions, primarily serving markets in North America and Europe.20.A. The transaction, which was announced in January 2021, is expected to be finalized in the first half of 2021. The company is also looking to expand its market presence in North America and Europe, focusing on the introduction of new therapeutic candidates that are currently in development.
Who invested in Kymab
6 investors across 1 round
See all investors in Kymab
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 24, 2016
Amount
$101M
Investors
Questions about Kymab
Who invested in Kymab?
Kymab has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kymab raised?
Kymab has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kymab last raise money?
Kymab's most recent round on record is a Series C, in Nov 2016.
What does Kymab do?
Kymab is a pharmaceuticals company.
Where is Kymab headquartered?
Kymab is headquartered in Cambridge, UK.
Which VCs invest in companies like Kymab?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Kymab's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Kymab? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.